Wednesday, May 18, 2016

Movimientos anormales y embarazo / Abnormal movements and pregnancy

›
Eduardo Palacios, Ángela Viviana Navas, Repertorio de Medicina y Cirugía, Available online 30 April 2016, ISSN 0121-7372, doi:10.1016/j.repe...
Tuesday, May 17, 2016

Mitochondrial disorders in children: toward development of small‐molecule treatment strategies

›
Werner JH Koopman, Julien Beyrath, Cheuk‐Wing Fung, Saskia Koene, Richard J Rodenburg, Peter HGM Willems, Jan AM Smeitink. EMBO Molecular Me...
Sunday, May 15, 2016

The Effect of Piracetam on Friedreich Ataxia.

›
Elmal AD , Gündüz A , Uzun N , Apaydn H , Kzltan G; Clinical Neuropharmacology [2016, 39(3):159-160] DOI: 10.1097/WNF.0000000000000148
Friday, May 13, 2016

Can other gene therapy developers avoid Glybera's fate?

›
FiercePharma, by Tracy Staton | May 4, 2016. Glybera, the treatment for an ultra-rare disease called lipoprotein lipase deficiency approv...
Thursday, May 12, 2016

Responsible implementation of expanded carrier screening

›
Lidewij Henneman, Pascal Borry, Davit Chokoshvili, Martina C Cornel, Carla G van El, Francesca Forzano, Alison Hall, Heidi C Howard, Sandra ...
Wednesday, May 11, 2016

Advances in management of movement disorders in children

›
Anne Koy, Jean-Pierre Lin, Terence D Sanger, Warren A Marks, Jonathan W Mink, Lars Timmermann, The Lancet Neurology, Volume 15, Issue 7, Jun...
Tuesday, May 10, 2016

Iron chelation in the treatment of neurodegenerative diseases.

›
Dusek P, Schneider SA, Aaseth J. J Trace Elem Med Biol. 2016 Mar 24. pii: S0946-672X(16)30047-5. doi: 10.1016/j.jtemb.2016.03.010. Several...
Monday, May 9, 2016

Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine

›
Nazish Sayed, Chun Liu, Joseph C. Wu, Journal of the American College of Cardiology, Volume 67, Issue 18, 10 May 2016, Pages 2161-2176, ISSN...
Saturday, May 7, 2016

Constrictive Pericarditis Versus Restrictive Cardiomyopathy?

›
Mario J. Garcia, Journal of the American College of Cardiology, Volume 67, Issue 17, 3 May 2016, Pages 2061-2076, ISSN 0735-1097, doi:10.101...
Friday, May 6, 2016

Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia

›
DUBLIN, IRELAND -- (Marketwired) -- 05/05/16 -- Horizon Pharma plc today announced that it has completed target enrollment of its Phase 3 st...